The prevalence and risk of skin cancer have been increasing over past three decades.
| INTRODUCTION
Cells in a multicellular organism undergo cell division in a distinctive cell cycle-dependent manner. In normal cell division, the cell cycle is well programmed with antagonizing effect of cell cycle promoters and inhibitors. The cell cycle promoters are, in general, the products of moderately expressed proto-oncogenes, whereas the inhibitors are the products of tumor suppressor genes whose function is to prevent the transition of the cell from one phase to another phase of cell cycle. Common proto-oncogenes such as Ras, Myc, and Fos, are activated to become oncogenes by mutation. The mutations in the tumor suppressor genes are recessive, and mutant phenotype is only expressed in homozygous conditions. As the antagonizing activities of the proto-oncogene and tumor suppressor genes are required for the controlled proliferation of the cells, the mutation in these genes can result in imbalance of cellular homeostasis leading to cancer. The skin is considered as the largest organ in the human body, and it protects against heat, sunlight, injury, and infections. Excessive exposure to ultraviolet (UV) radiation present in the sunlight is the major cause of skin cancer. 1 UV radiation produces harmful effect to the skin through many ways including (i) DNA damage, (ii) production of reactive oxygen species (ROS), (iii) activation of inflammatory signaling pathways. 2 Other causes of skin cancer include exposure to chemicals, genetic vulnerability, and the viruses such as human papillomavirus (HPV).
Skin cancer can mainly be classified into two types based on the type of cells from which it has originated, and they are nonmelanoma skin cancer (NMSC) and melanoma skin cancer. 3 NMSC includes basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), both arise from the epidermis. BCC and SCC are the most frequently diagnosed malignancy which accounts for more than 80% and 16% of overall skin cancer, respectively. 4 NMSC typically has a good prognosis and low metastatic capability compared to melanoma skin cancer.
Melanoma is the most aggressive type of skin cancer, arises from melanocytes which locate in the bottom layer of skin epidermis. 5 In addition to melanocytes, malignant melanoma also stems from other mucosal surfaces including oral cavity, genital mucosa, and gastrointestinal sites. Melanocytes, derived from the neuronal crest, are distinctive that they produce a pigment called melanin. 6 Malignant melanoma is a poorly distinct type of skin cancer and has a survival rate of fewer than 10 years when getting into metastasis. The treatment for melanoma includes surgical removal of tumor tissue through laser and cryosurgery (freeze the cells with liquid nitrogen) followed by adjuvant chemotherapy. 3 
| EPIGENETIC AND CANCER
Epigenetics is defined as heritable changes in gene expression and repression that are not due to any alteration in underlying DNA reading frame in the genome. 9 The major epigenetic changes include DNA methylation of cytosine nucleotide in CpG islands at promoter region of DNA, histone modifications such as histone methylation and histone acetylation, and miRNA-mediated gene regulations.
Other epigenetic changes are phosphorylation of serine and threonine residues, and ubiquitination and sumoylation of lysine residues at histone cores. 10 Combinations of these modifications characterize the chromatin configuration and thus the accessibility of genes for transcription. Epigenetic changes constantly occur during the life of cells. Therefore, these epigenetic modifications play a critical role in cell proliferation, differentiation, apoptosis, growth, and development of a cell and an organism including the process of tumorigenesis and metastasis as depicted in Figure 1 . The eukaryotic chromatin network differentiates into the transcriptionally active euchromatin and transcriptionally inactive heterochromatin.
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The euchromatin region is relatively more diffused and associated with active transcription throughout the cell cycle. The DNA in these regions is usually hypomethylated, and the core histones associated with the euchromatin regions often subject to demeth- Thus, an altered DNA methylation profile is hallmark of almost all types of human cancers, including skin cancer. [20] [21] [22] [23] S-adenosyl methionine (SAM) functions as a methyl group donor, and the reaction catalyzes by a group of enzymes called as DNA methyltransferases (DNMTs). 24 The eukaryotic genome encodes two types of DNMTs which are the maintenance methyltransferases (DNMT1) and the de novo methyltransferases (DNMT3A and DNMT3B). DNMT3A
and DNMT3B are essential for de novo methylation in the early stages of embryo development, whereas DNMT1 is largely responsible for maintaining the methylation pattern by adding methyl groups to hemimethylated DNA sites. repressor complexes. 26 In addition to the MBDs, methylated regions also bind with histone deacetylases (HDACs) and other chromatin remodeling proteins. 7, 26 HDACs remove the acetyl groups from histone tails which lead to chromatin condensation. 26 Hypomethylation occurs in the regulatory promoter region of many genes that are involved in cell cycle regulation, invasion, angiogenesis, and metastasis. Moreover, this hypomethylation at centromeric regions of the chromosomes is associated with genomic instability.
In contrast to DNA hypermethylation, a global level DNA hypomethylation was observed when analyzed melanoma through DNA F I G U R E 1 Events involved in UVB-induced skin cancer and metastasis. Exposure to UVB induces oxidative stress, inflammation, and DNA damage in keratinocytes at the epidermis of the skin. Excessive exposure to UVB further induces the expressions of oncogenes and suppresses tumor promoter genes through genetic and epigenetic mechanisms, thereby transforms the normal cells into the tumor cell. At the later stage, primary tumor cells get metastasized into distinct body organs such as bone, lungs, lymph, and brain by expressing metastasis-inducing genes methylation landscape epigenome analysis. 28 Multiple studies have revealed that global DNA hypomethylation events are major characteristics of many cancers including melanoma and contribute to genomic instability by activating retrotransposons. 29, 30 Guo and co-workers analyzed 34 primary cutaneous melanoma samples for their global methylation status and observed more than 98% loss of methylation and only about 2% changes were due to the gain of methylation. Several studies have shown that the expression level of histone modifying enzymes is linked with unregulated proliferation in melanoma. For instance, enhancer of zeste homolog 2 (EZH2) is a histone methylation transferase enzyme belonging to H3K27-KMT6 family. 9 Hyperactivation of EZH2 has been observed in melanoma as well as in other cancers such as prostate and lymphoma. 32 Higher expression of EZH2 is associated with the downregulation of cell cycle inhibitors involved in cell cycle progression. 25 EZH2 also mediate transcriptional inactivation of E-cadherin, which is involved in cell-cell interactions. 26 Higher expression of SETDB1, a member of H3K9-KMT1 family, has been found in melanoma. The higher expression of SETDB1 increase the aggressiveness of the melanoma by forming complexes with SUV39H1 and other H3K9 methyltransferases. 32 In cutaneous melanoma, the anti-apoptotic proteins such as Bcl-2 and Bcl-xl were found to be upregulated, whereas the pro-apoptotic proteins such as Bax, Bim, Bak, Bid, Apaf1, and caspase-3 were found to be downregulated. 10 Apparently, the changes in the redox cycling of pro-and anti-apoptotic proteins are linked with the aberrant expression of HATs and HDACs in melanoma. HDACs. 34 In this review, we summarize two most studied phytochemicals such as sulforaphane and tea catechins/epicatechins having epigenetic regulations in the prevention and therapeutics of skin cancer. Table 1 shows the summary of studies related to epigenetic modifications on various cancer types by sulforaphane and tea catechins/ epicatechins.
| SULFORAPHANE
Sulforaphane, an isothiocyanate, is majorly found in cruciferous vegetables such as broccoli, cauliflower, broccoli sprouts, and cabbage.
Consumption of SFN-rich diet such as broccoli sprouts has been shown to inhibit the UVB-induced inflammation and thereby reduces the risk of UV-exposed skin carcinogenesis. 35, 36 Furthermore, the im- Table 1 . Therefore, in this review, we exclusively focused on the epigenetic modulatory effect of EGCG in skin cancer.
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EGCG has been shown to act as an epigenetic regulator of skin cancer, which inhibits the DNA methylation in SCC-13 and A431 skin cancer cell lines by suppressing the expression of DNMTs. 25 In accordance, topical application of EGCG restores the UVB-induced global hypomethylation in the SKH-1 hairless mouse model. 51 In an another study, EGCG has been shown to reactivates key tumor suppressor genes such as cip1/p21 and p16INK4a by reducing DNA methylation and increasing histone acetylation in human skin cancer cells. 47 Several studies state that EGCG stimulates the demethylation by inhibiting the activity of DNMTs through several mechanisms. EGCG is shown to bind directly to the DNMTs active site. 46 Second, EGCG enhances the conversion of SAM to S-adenosyl-L-homocysteine (SAH) and thereby indirectly inhibits DNMTs. 52 EGCG also decreases the histone methylation at lysine 9 of histone H3; these modifications lead to increased expression of cell cycle inhibitors such as cip1/p21 and p27 in human skin cancer cells. 10 Reversion-inducing cysteine-rich protein with kazal motifs (RECK) is a tumor suppressor protein, and it is shown to decrease the transcriptional activation of matrix metalloproteases which are responsible for the metastatic progression of the cancer cell. EGCG has been shown to demethylate the promoter of RECK and thereby restore the transcriptional activation of RECK in SCC cells. 53 In addition to DNA methylation inhibitory activity, EGCG also shown to inhibit the expressions of class I HDACs and thereby upregulate the levels of tumor suppressor proteins such as Cip1/WAF1/p21, p16, and p53 in melanoma cells. 54 Treatment of skin cancer cells with EGCG antagonizes the Bmi-1, a PcG protein, and enhances cell survival, involved in the epigeneticmediated gene silencing of Cdk inhibitors. 55 Furthermore, EGCG is also shown to downregulate PcG protein levels via proteasome-assisted degradation in skin cancer cells. 56 The topical application of the combinations of EGCG with other drugs such as 5-fluorouracil, imiquimod, ingenol mebutate, and retinoids has been shown to be more effective in treating UVB-induced skin cancer than the individual compound. to investigate the impact on physiological effects of skin cancer. As cancer is the multistage process, it required multitargeted approach, which will be possible when we use combinatorial therapy with available drug or epigenetic modulatory compounds. This will further pave the way to develop epigenetic-based diet as well as nutraceuticals to deal with the deadly disease of skin cancer.
